These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36907808)

  • 21. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
    Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of Indocyanine Green to Aid in Identifying Sentinel Lymph Nodes in Merkel Cell Cancer.
    Knackstedt RW; Knackstedt T; Gastman B
    J Surg Res; 2018 Dec; 232():365-368. PubMed ID: 30463742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer.
    Cabrera S; Bebia V; Franco-Camps S; Forcada C; Villasboas-Rosciolesi D; Navales I; Pérez-Benavente A; Gil-Moreno A
    Int J Gynecol Cancer; 2020 Mar; 30(3):311-317. PubMed ID: 31992599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of indocyanine green combined with methylene blue staining in sentinel lymph node biopsy of breast cancer.
    Xu Y; Yuan S; Chen M; Gong K; Liu Y; Li S; Xiong F; Pan Y; Cao J; Gong J; Luo N
    Gland Surg; 2022 Sep; 11(9):1489-1496. PubMed ID: 36221275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial.
    Jung SY; Han JH; Park SJ; Lee EG; Kwak J; Kim SH; Lee MH; Lee ES; Kang HS; Lee KS; Park IH; Sim SH; Jeong HJ; Kwon Y; Lee DE; Kim SK; Lee S
    Ann Surg Oncol; 2019 Aug; 26(8):2409-2416. PubMed ID: 31065958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of fluorescence endoscopy with methylene blue dye and indocyanine green dual-tracer method in sentinel lymph node biopsy for women with breast cancer.
    Ou C; Luo Y; He L; Zhu D; Zhu Y; Chen Q; Xu X; Zhang P
    Gland Surg; 2023 Jun; 12(6):780-790. PubMed ID: 37441014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved false-negative rates using a novel patient selection flowchart in initially biopsy-proven node-positive breast cancer undergoing blue-dye alone guided sentinel lymph node biopsy after neoadjuvant chemotherapy.
    Chen M; Li S; Huang M; Guo J; Huang X; Guo W; Chen L; Lin Y; Jacobs L; Wang C; Fu F
    Breast Cancer Res Treat; 2022 Nov; 196(2):267-277. PubMed ID: 36100784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the benefit of using blue dye in addition to indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer.
    Guo W; Zhang L; Ji J; Gao W; Liu J; Tong M
    World J Surg Oncol; 2014 Sep; 12():290. PubMed ID: 25239029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous contrast-enhanced ultrasound for localization and diagnosis of sentinel lymph node in early breast cancer.
    Liu J; Liu X; He J; Gou B; Luo Y; Deng S; Wen H; Zhou L
    Sci Rep; 2019 Sep; 9(1):13545. PubMed ID: 31537856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-port endoscopic-sentinel lymph node biopsy combined with indocyanine green and carbon nanoparticles in breast cancer.
    Wang ZH; Gang TR; Wu SS; Lu C; Gao GX; Xu W; Ding GQ; Qu X; Zhang ZT
    Surg Endosc; 2023 Oct; 37(10):7591-7599. PubMed ID: 37460818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial.
    Jung SY; Kim SK; Kim SW; Kwon Y; Lee ES; Kang HS; Ko KL; Shin KH; Lee KS; Park IH; Ro J; Jeong HJ; Joo J; Kang SH; Lee S
    Ann Surg Oncol; 2014 Apr; 21(4):1254-9. PubMed ID: 24356798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye.
    Buda A; Papadia A; Di Martino G; Imboden S; Bussi B; Guerra L; De Ponti E; Reato C; Gasparri ML; Crivellaro C; Mueller M
    J Minim Invasive Gynecol; 2018; 25(3):455-460. PubMed ID: 29032256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triple mapping for axillary staging after neoadjuvant therapy: Axillary reverse mapping with indocyanine green and dual agent sentinel lymph node biopsy.
    Tasdoven I; Balbaloglu H; Erdemir RU; Bahadir B; Guldeniz Karadeniz C
    Medicine (Baltimore); 2022 Dec; 101(52):e32545. PubMed ID: 36596061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer.
    Wishart GC; Loh SW; Jones L; Benson JR
    Eur J Surg Oncol; 2012 Aug; 38(8):651-6. PubMed ID: 22704050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of learning curve with Indocyanine Green (IcG) versus blue dye for sentinel lymph node biopsy in breast cancer.
    Hounschell CA; Kilgore LJ; Pruitt P; Wilder C; Balanoff CR; Wagner JL; Baker J; Chollet-Hinton L; Larson KE
    Am J Surg; 2024 Jan; 227():218-223. PubMed ID: 37838506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of fluorescein combined with methylene blue in sentinel lymph node biopsy of breast cancer.
    Li L; Gao N; Yang AQ; Xu WH; Ding Y; Chu J; Lin XN; Liu JQ
    Sci Rep; 2021 Jun; 11(1):12119. PubMed ID: 34108563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of indocyanine green and the HyperEye system for detecting sentinel lymph nodes in breast cancer within a population of European patients: a pilot study.
    Coufal O; Fait V
    World J Surg Oncol; 2016 Dec; 14(1):299. PubMed ID: 27905950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indocyanine green and methylene blue dye guided sentinel lymph node biopsy in patients with penile cancer (PeCa): results of 50 inguinal basins assessed at a single institution in India.
    Amaresh M; Sharma RM; Choudhary A; Shah A; Rao BV; Rao TS
    World J Urol; 2024 Sep; 42(1):542. PubMed ID: 39331184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Dual Dye Technique for Sentinel Lymph Node Biopsy in Breast Cancer: Two-Arm Open-Label Parallel Design Non-Inferiority Randomized Controlled Trial.
    Suhani ; Kumar U; Seenu V; Sodhi J; Joshi M; Bhattacharjee HK; Khan MA; Mathur S; Kumar R; Parshad R
    World J Surg; 2023 Sep; 47(9):2178-2185. PubMed ID: 37171588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel lymph node mapping with indocyanine green compared to blue dye tracer in gynecologic malignancies-A single center experience of 218 patients.
    Pölcher M; Matz S; Braun M; Brambs C; Beer M; Hamann M
    J Surg Oncol; 2021 Mar; 123(4):1092-1098. PubMed ID: 33333589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.